Strides Pharma Science and Orbicular Pharmaceutical Technologies Private Limited (Orbicular) today informed that they have entered into a strategic partnership to develop, manufacture and commercialize nasal sprays for the global markets.
Alembic Pharmaceuticals on Tuesday said it has acquired the balance 40% stake in Aleor Dermaceuticals from its JV Partner Orbicular Pharmaceutical Technologies to strengthen its skin-related manufacturing and marketing footprint.